Drugmaker AstraZeneca on Wednesday said that its experimental breast cancer treatment improved patient survival without the disease getting worse in a study, a positive outcome in the development of the therapy key to the company's pipeline.

The results showed statistically significant and clinically meaningful improvement in progression-free survival compared with the standard-of-care treatment, the company said.

AstraZeneca Plc’s experimental breast cancer pill helped patients live for longer without their disease worsening, the UK drugmaker said.

A scanner developed in Aberdeen could be potentially "extraordinary" for diagnosing and treating breast cancer, it has been claimed. Scientists from the University of Aberdeen used a prototype version of the new Field Cycling Imager (FCI) scanner to examine the breast tissue of patients newly-diagnosed with cancer.

The world’s first and only ultra-low magnetic scanner could change the way breast cancer is diagnosed and treated, experts say. Get a free dose of heath care news and wellness tips delivered to your inbox each Tuesday morning.

The world’s first and only ultra-low magnetic scanner could change the way breast cancer is diagnosed and treated, experts say. Developed by scientists at the University of Aberdeen, it means patients could receive fewer surgeries and more individually tailored treatments.